Tuesday, 12 December, 2017

Only One-third of Marijuana Extracts Accurately Labeled, Researchers Say

HealthNew Study Finds CBD Products Still Dogged by Labeling Errors Bruce Barcott HealthNew Study Finds CBD Products Still Dogged by Labeling Errors Bruce Barcott
Melissa Porter | 10 November, 2017, 03:20

Researcher Marcel Bonn-Miller, of the University of Pennsylvania Perelman School of Medicine, worked with colleagues from the Veterans Affairs San Diego Health Care System, nonprofit research organization RTI International, marijuana advocacy group Americans for Safe Access, and Johns Hopkins University School of Medicine. Only 31 percent of the products were labeled accurately; 43 percent contained higher concentrations of cannabidiol than indicated on the label, and 26 percent contained lower concentrations of cannabidiol than indicated on the label. While medical marijuana marketers claim positive impact of products for chronic pain, seizures, PTSD and many other ailments, the labeling of products is correct only in 31 percent of the cases evaluated by the study team. This degree of mislabeling poses safety and efficacy issues for consumers, particularly given the fact that these unapproved CBD formulations are often used to treat children with intractable epilepsy. The federal government considers cannabis a Schedule 1 controlled unsafe substance, and is not involved in production, labeling and distribution at the state level.

CBD is now legal in all European Union countries (except Slovakia), Canada and some states within the U.S., where there are already CBD-based cannabis products such as lotions, oils, creams, capsules and even bottled water.

Buyer beware. almost 75 percent of CBD marijuana extracts sold online are mislabeled, with numerous products containing little to none of the active ingredient, according to a study helmed by a University of Pennsylvania researcher.

Until these products are regulated, be wary of any CBD supplements you see online. Business experts estimate that the market for CBD products will grow to more than $2 billion in consumer sales within the next three years. "The biggest implication [of the study] is that many of these patients may not be getting the proper dosage; they're either not getting enough for it to be effective or they're getting too much".

In addition, the study found that 21 percent of the products contained THC that wasn't listed on the label, at concentrations of up to 6.4 mg/mL.

"Parents could be giving their kids THC without knowing it", says Bonn-Miller.

Additional studies should monitor the cannabidiol marketplace for changes in labeling accuracy over time, and compare internet products with those sold in dispensaries, the researchers said. This means some cannabidiol products may be labeled inaccurately. "It's insane to have less oversight and information about a product being widely used for medicinal purposes, especially in very ill children, than a Hershey bar".